Interv Akut Kardiol. 2005;4(1):41-44

LATE THROMBOSIS IN DRUG ELUTING STENT

Zdeněk Coufal1, Tomáš Fiala2, Robert Náplava2, Martin Gřiva1, Martin Slabák1
1 Pracoviště invazivní a intervenční kardiologie, Interní klinika IPVZ, Krajská nemocnice T. Bati, a.s., Zlín
2 Interní klinika, Krajská nemocnice T. Bati a.s., Zlín

The use of drug eluting stents (DES) reduces the risk of restenosis. Prolonged antiplatelet therapy with ASA + thienopyridin is necessary due to delayed reendotelisation of DES, and potentialy higher risk of the in stent thrombosis. The risk of thrombosis in DES is equal to that in bare metal stents in case of prolonged antiplatelet therapy. The authors present a case of late thrombosis in paclitaxel eluting stent due to premature cessation of dual antiplatelet therapy.

Keywords: Key words: drug eluting stents, late thrombosis, dual antiplatelet therapy.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Coufal Z, Fiala T, Náplava R, Gřiva M, Slabák M. LATE THROMBOSIS IN DRUG ELUTING STENT. Interv Akut Kardiol. 2005;4(1):41-44.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Morice MC, et al. XXIII congres European Society of Cardiology, Stockholm 2001.
    2. Morice MC, Serruys PW, Sousa JE, et al. For the RAVEL Study Group: A randomized comparison of sirolimus - eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002; 346: 1773-1780. Go to original source... Go to PubMed...
    3. Moses J, Leion MB, Popma JJ, et al. For SIRIUS Investigators: Sirolimus - eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323. Go to original source... Go to PubMed...
    4. Colombo A, Drzewiecki J, Banning A, et al. For the TAXUS II Study Group: Randomized study to assess the effectiveness of slow - based paclitaxel eluting stents for coronary artery lesions. Circulation 2003; 108: 788-794. Go to original source... Go to PubMed...
    5. Stone GW, Ellis SG, Cox DA, et al. For the TAXUS - IV Investigators: A polymer - based paclitaxel - eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231. Go to original source... Go to PubMed...
    6. Jeremias A, et al. Stent Thrombosis Afeter Successful Sirolimus-Eluting Stent Implantation. Circulation 2004; 109: 1930-1932. Go to original source... Go to PubMed...
    7. Stone GV, Ellis SG, Coxa DA, et al. One Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial. Circulation 2004; 109: 1942-1947. Go to original source... Go to PubMed...
    8. Urban P. e-CYPHER Registry - PCR 2004 Update. PCR, Paris 2004.
    9. Silber S. ESC GUidelines on Antithrombotic Treatment During Percutaneous Coronary Intervention. PCR, Paris 2004.
    10. Beck DS. First Randomized Compariosin of Cypher and Taxus Shows No Significant Differences. Associated Meeting ACC 2004, New Orleans, LA.

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.